All lobbying filings
BROWNSTEIN HYATT FARBER SCHRECK, LLP
Lobbying for NOVARTIS · Multinational biopharmaceutical company
Filing
3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 16, 2025
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
2
-
MAXWELL HUNTLEY New on this filingPreviously held: NSC, EOP, Dir Defense Policy and Strategy; HASC, Prof. Staff; Sen John Kennedy, Nat Security Adv; Rep. Rob Wittman, Sr Advisor; Rep Rob Wittman, Military LA/Defense Policy Adv; Rep Wittman, Leg Aide; Rep Wittman, LC; Rep Jack Bergman, Staff Assistant
-
STEPHEN HOLLAND New on this filingPreviously held: Senior Health Counsel, Health Counsel - House Energy and Commerce Committee (Rep. Frank Pallone); Counsel, Legislative Assistant - Rep. Kurt Schrader
Government bodies contacted
3
Bills named in this filing
1
Lobbying activity
1
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act Most Favored Nation (MFN) policy